These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22339458)

  • 1. Conference scene: recent advancements in immunotherapy.
    Finegold I
    Immunotherapy; 2012 Feb; 4(2):149-50. PubMed ID: 22339458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conference Scene: novelties in immunotherapy.
    Mitsias DI; Kalogiros LA; Papadopoulos NG
    Immunotherapy; 2013 Oct; 5(10):1033-7. PubMed ID: 24088073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous Immunotherapy Safety: Incidence per Surveys and Risk Factors.
    Sánchez-Borges M; Bernstein DI; Calabria C
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):25-39. PubMed ID: 31761119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report.
    Burks AW; Calderon MA; Casale T; Cox L; Demoly P; Jutel M; Nelson H; Akdis CA
    J Allergy Clin Immunol; 2013 May; 131(5):1288-96.e3. PubMed ID: 23498595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
    Malling HJ; Bousquet J
    Clin Allergy Immunol; 2008; 21():343-58. PubMed ID: 18828516
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations.
    Cox L; Calderón M; Pfaar O
    Immunotherapy; 2012 Jun; 4(6):601-16. PubMed ID: 22788128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of sublingual immunotherapy: an analysis of literature.
    Ciprandi G; Agostinis F; Amoroso S; Ariano R; Barbato A; Bassi M; Cadario G; Campi P; Cardinale F; Romano C; Incorvaia C; Danneo R; Dal Bo S; Di Gioacchino M; Fiocchi A; Galimberti M; Galli E; Giovannini M; La Grutta S; Lombardi C; Marcucci F; Marseglia GL; Mastrandrea F; Minelli M; Nettis E; Novembre E; Ortolani C; Pajno G; Piras PP; Passalacqua G; Patriarca G; Pucci S; Quercia O; Romano A; Schiavino D; Sforza M; Tosca MA; Tripodi S; Zambito M; Puccinelli P; Frati F
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():21-6. PubMed ID: 18924463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy: a comprehensive review.
    Cox LS; Larenas Linnemann D; Nolte H; Weldon D; Finegold I; Nelson HS
    J Allergy Clin Immunol; 2006 May; 117(5):1021-35. PubMed ID: 16675328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
    Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Subcutaneous and Sublingual Aeroallergen Immunotherapy: What Is New?
    Komlósi ZI; Kovács N; Sokolowska M; van de Veen W; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):1-14. PubMed ID: 31761112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific immunotherapy--past--present--future].
    Kägi MK
    Praxis (Bern 1994); 1998 Sep; 87(40):1330-4. PubMed ID: 9816927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and current status of asthma and associated allergic diseases in Taiwan- ARIA Asia-Pacific Workshop report.
    Yeh KW; Chiang LC; Huang JL
    Asian Pac J Allergy Immunol; 2008 Dec; 26(4):257-64. PubMed ID: 19317345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances and highlights in allergen immunotherapy: On the way to sustained clinical and immunologic tolerance.
    Berings M; Karaaslan C; Altunbulakli C; Gevaert P; Akdis M; Bachert C; Akdis CA
    J Allergy Clin Immunol; 2017 Nov; 140(5):1250-1267. PubMed ID: 28941667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in allergen-specific immunotherapy.
    Passalacqua G; Compalati E; Canonica GW
    Curr Drug Targets; 2009 Dec; 10(12):1255-62. PubMed ID: 19909232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific immunotherapy in children.
    Bufe A; Roberts G
    Clin Exp Allergy; 2011 Sep; 41(9):1256-62. PubMed ID: 21518041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy.
    Heinzerling L; Worm M; Bergmann KC; Zuberbier T
    J Dtsch Dermatol Ges; 2006 May; 4(5):428-33; quiz 434-5. PubMed ID: 16686612
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized trial of subcutaneous allergy immunotherapy in inner-city children with asthma less than 4 years of age.
    de Vos G; Viswanathan S; Pichardo Y; Nazari R; Jorge Y; Ren Z; Serebrisky D; Rosenstreich D; Wiznia A
    Ann Allergy Asthma Immunol; 2021 Apr; 126(4):367-377.e5. PubMed ID: 33418053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of allergen and non-specific immunotherapy: past achievements, current applications and future outlook.
    Pajno GB; Nadeau KC; Passalacqua G; Caminiti L; Hobson B; Jay DC; Arasi S; Chiera F; Salzano G
    Expert Rev Clin Immunol; 2015 Jan; 11(1):141-54. PubMed ID: 25454510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy for allergic Rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
    Calderón MA; Penagos M; Durham SR
    Clin Allergy Immunol; 2008; 21():359-75. PubMed ID: 18828517
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy: when to initiate treatment in children.
    Finegold I
    Allergy Asthma Proc; 2007; 28(6):698-705. PubMed ID: 18201435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.